TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8899314

Group type: EXPERIMENTAL
Intervention: Ukrain medication
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no Ukrain)
Number of subjects: 32
Study: 2027922

Group type: EXPERIMENTAL
Intervention: Active marijuana (M; 2.3% delta‐9‐THC) with 20 s breathhold
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo marijuana (P; 0.0% delta‐9‐THC) with 20 s breathhold
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Active marijuana (M; 2.3% delta‐9‐THC) with no breathhold
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo marijuana (P; 0.0% delta‐9‐THC) with no breathhold
Number of subjects: 10
Study: 6385356

Group type: EXPERIMENTAL
Intervention: Acyclovir combined with dilute betamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adenine arabinoside combined with dilute betamethasone
Number of subjects: 0
Study: 31830294

Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation in study cases with previous ocular surgeries
Number of subjects: 133
Study: 29788433

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (400 g daily for 2 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonfermented milk (400 g daily for 2 weeks)
Number of subjects: 14
Study: 27565902

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 13935

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13935
Study: 24890124

Group type: EXPERIMENTAL
Intervention: Cryoprobe sampling
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional forceps sampling
Number of subjects: 77
Study: 22130786

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Alfacalcidol (1 μg)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Raloxifene + Alfacalcidol (R + D)
Number of subjects: 169
Study: 19875998

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 2273

Group type: EXPERIMENTAL
Intervention: Higher waist circumference
Number of subjects: 2273

Group type: EXPERIMENTAL
Intervention: Both higher BMI and waist circumference
Number of subjects: 2273

Group type: EXPERIMENTAL
Intervention: BMI and waist circumference
Number of subjects: 2273
Study: 18472528

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouth rinse without alcohol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Chlorhexidine mouth rinse with alcohol
Number of subjects: 21
Study: 16344019

Group type: EXPERIMENTAL
Intervention: Active acupuncture (including electroacupuncture), mean 16.9 sessions over 10.5 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 33
Study: 12161329

Group type: EXPERIMENTAL
Intervention: Repeated trials of familiar leg bicycling exercise with dead-space induced hypercapnia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control paradigms involving either repeated exercise alone or resting dead space alone
Number of subjects: 0
Study: 10628889

Group type: EXPERIMENTAL
Intervention: Reboxetine (4-6 mg/day)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Imipramine (50-100 mg/day)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 347
Study: 8688982

Group type: EXPERIMENTAL
Intervention: Skenan (30 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Moscontin (30 mg)
Number of subjects: 12
Study: 2091623

Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (400 to 1600 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Tranylcypromine
Number of subjects: 5
Study: 7350799

Group type: EXPERIMENTAL
Intervention: Aerosolized terbutaline (0.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Subcutaneous terbutaline (0.5 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31038809

Group type: EXPERIMENTAL
Intervention: Conditioning pain modulation at 30% of PTT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conditioning pain modulation at 70% of PTT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conditioning pain modulation at 100% of PTT
Number of subjects: 20

Group type: COMPARATOR
Intervention: No conditioning (baseline and post-recordings)
Number of subjects: 20
Study: 27734305

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 16
Study: 26063588

Group type: EXPERIMENTAL
Intervention: Guidance on introducing five vegetables (one per day) as first foods repeated over 15 days
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 146
Study: 23335357

Group type: EXPERIMENTAL
Intervention: IV ferric carboxymaltose (FCM; two injections of 750 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral iron therapy
Number of subjects: 0
Study: 21514093

Group type: EXPERIMENTAL
Intervention: Hydrocortisone at 1.5 μg/kg per minute (STRESS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone at 3.0 μg/kg per minute (PHARM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 19517601

Group type: EXPERIMENTAL
Intervention: Natural physical factors (sun, air, and sea water baths) in specialized children's sanatoria (group 1, n = 278)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Conventional treatment in municipal outpatient settings (group 2, n = 278)
Number of subjects: 556
Study: 17096851

Group type: EXPERIMENTAL
Intervention: Cervical anterior discectomy without fusion
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Cervical anterior discectomy with fusion using a stand alone cage
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Cervical anterior discectomy with implantation of a Bryan's disc prosthesis
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 270
Study: 15150487

Group type: EXPERIMENTAL
Intervention: Statins (simvastatin and pravastatin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11356728

Group type: EXPERIMENTAL
Intervention: Antibiotic
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 9067046

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms.kg‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 90
Study: 7960904

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 954

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: All cholecystectomy patients
Number of subjects: 954
Study: 3595575

Group type: EXPERIMENTAL
Intervention: Gastrozepin 10 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 30045356

Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT) combined with McIsaac clinical score
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: McIsaac score of 3 or more
Number of subjects: 605
Study: 28688514

Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia (CEA)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Continuous preperitoneal wound catheters (CPA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both groups (CPA and CEA)
Number of subjects: 98
Study: 27338997

Group type: EXPERIMENTAL
Intervention: Enhanced intervention (integrated intervention for T2DM and depression employing patient prioritized planning)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Basic intervention (integrated intervention alone)
Number of subjects: 78
Study: 25549238

Group type: EXPERIMENTAL
Intervention: Neonatal HBV vaccination
Number of subjects: 39292

Group type: COMPARATOR
Intervention: Catch-up vaccination
Number of subjects: 39292

Group type: COMPARATOR
Intervention: Booster at age 10-14 years
Number of subjects: 39292
Study: 22152671

Group type: EXPERIMENTAL
Intervention: Single Category Implicit Association Tests (SC‐IATs) for alcohol
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Self-reports of substance use
Number of subjects: 378
Study: 19630495

Group type: EXPERIMENTAL
Intervention: Tramadol in addition to narcotic pain medications
Number of subjects: 50

Group type: COMPARATOR
Intervention: Narcotics and acetaminophen alone
Number of subjects: 50
Study: 18769906

Group type: EXPERIMENTAL
Intervention: Ascorbate (1 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17230043

Group type: EXPERIMENTAL
Intervention: KYSt‐4 (Nohime) strawberry variety
Number of subjects: 2

Group type: COMPARATOR
Intervention: KYSt‐10 strawberry variety
Number of subjects: 2

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 2
Study: 14604303

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 vaginal pessary (5% concentration) used at bedtime for 14 days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 vaginal pessary
Number of subjects: 23
Study: 10924008

Group type: EXPERIMENTAL
Intervention: Sertraline 200 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8984354

Group type: EXPERIMENTAL
Intervention: Gang board
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Romberg's test
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Tandem gait
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: One‐leg‐stance
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Hopping
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Overall balance tests
Number of subjects: 220
Study: 1574966

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO) therapy, 150 U/kg given subcutaneously 3 times weekly
Number of subjects: 0
Study: 3930686

Group type: EXPERIMENTAL
Intervention: Premature formula (PF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Own mother's milk (OMM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Casein-predominant cow's milk formula (CF)
Number of subjects: 0
Study: 30479020

Group type: EXPERIMENTAL
Intervention: BRief Evaluation of Asthma THerapy intervention (7‐min shared decision‐making protocol)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dose-matched attention control
Number of subjects: 80
Study: 30257654

Group type: EXPERIMENTAL
Intervention: Teacher-led multifactorial back education programme
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 176
Study: 26465641

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine and fentanyl
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine, fentanyl and MgSO4
Number of subjects: 105
Study: 24449415

Group type: COMPARATOR
Intervention: Sonographic (US) images with arrows pointing to specific anatomic structures (Group A)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sonographic (US) images with arrows plus MRI/US fusion images (Group B)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sonographic (US) images with arrows (Group A)
Number of subjects: 54
Study: 21912268

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Attention control wait list (ACWL)
Number of subjects: 24
Study: 19834462

Group type: EXPERIMENTAL
Intervention: Weight Self-Stigma Questionnaire (WSSQ)
Number of subjects: 169
Study: 18555931

Group type: EXPERIMENTAL
Intervention: Branded risedronate sodium 35-mg tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Generic alendronic acid 70-mg tablet (Novopharm Limited)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Generic alendronic acid 70-mg tablet (Teva UK Limited)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Semisupine position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Novopharm tablet
Number of subjects: 20
Study: 15768430

Group type: EXPERIMENTAL
Intervention: 915 MHz microwaves (SAR 37 mW/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field (15 muT peak value)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heat shock at 41 degrees C
Number of subjects: 0
Study: 12425364

Group type: EXPERIMENTAL
Intervention: Epinastine 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10874374

Group type: EXPERIMENTAL
Intervention: Education on asthma
Number of subjects: 36

Group type: COMPARATOR
Intervention: Education on urinary tract infections
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group discussions
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CME activities
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Participation in CME
Number of subjects: 36
Study: 8621275

Group type: EXPERIMENTAL
Intervention: RRP plus RT
Number of subjects: 288

Group type: COMPARATOR
Intervention: RRP without RT
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: RRP plus neoadjuvant hormonal therapy
Number of subjects: 288

Group type: COMPARATOR
Intervention: RRP without hormonal therapy
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: RRP plus RT (no SV invasion)
Number of subjects: 288

Group type: COMPARATOR
Intervention: RRP without RT (no SV invasion)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: RRP plus RT (SV invasion)
Number of subjects: 288

Group type: COMPARATOR
Intervention: RRP without RT (SV invasion)
Number of subjects: 288

Group type: COMPARATOR
Intervention: RRP alone
Number of subjects: 288

Group type: COMPARATOR
Intervention: Adjuvant therapies
Number of subjects: 288
Study: 1874764

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and volitional exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Volitional exercise alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 10
Study: 7154888

Group type: EXPERIMENTAL
Intervention: Ramp slope of 20 W X min‐1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ramp slope of 30 W X min‐1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ramp slope of 50 W X min‐1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ramp slope of 100 W X min‐1
Number of subjects: 14
Study: 30548555

Group type: EXPERIMENTAL
Intervention: ProDesign R [PDR; size 25, .06 taper; Easy, Belo Horizonte, Brazil]
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mtwo [MO; size 25, .06 taper; VDW, Munich, Germany]
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reciproc [REC; size 25, .08 taper; VDW, Munich, Germany]
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All NiTi systems
Number of subjects: 30
Study: 30278067

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (10 mg/kg)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Topical TXA (3 g)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Topical placebo (60 ml physiological saline)
Number of subjects: 170
Study: 27794079

Group type: EXPERIMENTAL
Intervention: VT‐NIV
Number of subjects: 58

Group type: COMPARATOR
Intervention: PL‐NIV
Number of subjects: 58
Study: 25278226

Group type: EXPERIMENTAL
Intervention: Intravenous insulin therapy during lung resection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 64
Study: 23180045

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 20138941

Group type: EXPERIMENTAL
Intervention: Intervention groups focused on dietary changes including reduction of daily fat intake and increased intake of fruit, vegetables, and fiber.
Number of subjects: 62565

Group type: COMPARATOR
Intervention: Control group (active control)
Number of subjects: 62565

Group type: EXPERIMENTAL
Intervention: Polyp Prevention Trial (specific intervention)
Number of subjects: 62565
Study: 17358096

Group type: EXPERIMENTAL
Intervention: Rectally administered oxcarbazepine suspension (300 mg and 450 mg doses)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Oral administration of oxcarbazepine
Number of subjects: 10
Study: 15646602

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied three times within a single week
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluoride varnish applied in a single application
Number of subjects: 10
Study: 11591619

Group type: EXPERIMENTAL
Intervention: Short-term HTRs
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Long-term HTRs
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hypertensive patients
Number of subjects: 21
Study: 9520888

Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 69

Group type: COMPARATOR
Intervention: No suction drainage
Number of subjects: 69
Study: 7988364

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT; <= 25 mg daily)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no HCT)
Number of subjects: 69
Study: 3141491

Group type: EXPERIMENTAL
Intervention: 5 mg/day parenteral folinic acid
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 50 mg/week parenteral folinic acid
Number of subjects: 105

Group type: COMPARATOR
Intervention: No parenteral folinic acid (Control Group)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oral and enteral administration of folate (300 micrograms/day folic acid)
Number of subjects: 105
Study: 31280481

Group type: EXPERIMENTAL
Intervention: Anidulafungin 200 mg IV loading dose followed by 100 mg daily maintenance dose
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Anidulafungin treatment
Number of subjects: 79
Study: 27639927

Group type: EXPERIMENTAL
Intervention: Full nine-item Reproductive Coercion Scale (RCS)
Number of subjects: 4674

Group type: EXPERIMENTAL
Intervention: Short five-item Reproductive Coercion Scale (RCS)
Number of subjects: 4674
Study: 26372451

Group type: EXPERIMENTAL
Intervention: Hib‐MenC‐TT vaccine
Number of subjects: 433

Group type: COMPARATOR
Intervention: Hib + MCC vaccines
Number of subjects: 433
Study: 23444884

Group type: EXPERIMENTAL
Intervention: Educational board game
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no game)
Number of subjects: 67
Study: 22132800

Group type: EXPERIMENTAL
Intervention: Low GI meal without fructose (LGI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low GI meal with fructose beverage (LGIF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High GI meal (HGI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All trials (LGI, LGIF, HGI)
Number of subjects: 10
Study: 19364291

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg of MPH
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of MPH
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg of MPH
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: DAT SLC6A3 genotype
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: DRD2 genotype
Number of subjects: 58
Study: 16133044

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg, infused continuously over 15 min)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ibuprofen (initial dose of 10 mg/kg followed by two doses of 5 mg/kg each after 24 and 48 h)
Number of subjects: 44
Study: 10628766

Group type: EXPERIMENTAL
Intervention: Prednisone withdrawal (tapered over 8 weeks to 0 mg/day)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Prednisone maintenance (10 mg/day)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Prednisone withdrawal
Number of subjects: 266
Study: 7707112

Group type: EXPERIMENTAL
Intervention: High-dose experimental therapy
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Standard treatment or experimental agent
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Different therapies for a 6-month addition to life expectancy
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Treatment for a 5-year increase in length of survival
Number of subjects: 115

Group type: COMPARATOR
Intervention: Randomization to a clinical trial comparing high-dose with standard chemotherapy
Number of subjects: 115
Study: 2390879

Group type: EXPERIMENTAL
Intervention: Inosine, 50‐90 mg/kg daily in divided doses
Number of subjects: 36
Study: 7023207

Group type: EXPERIMENTAL
Intervention: Single-dose trimethoprim (200 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Five-day course of trimethoprim (200 mg b.d.)
Number of subjects: 96
Study: 31103123

Group type: EXPERIMENTAL
Intervention: Qigong practice (Guan Yin Zi Zai Gong level 1) for one hour per week for six weeks, encouraged to practice daily at home.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waiting list control group received general advice regarding low back pain management.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Qigong practice (Guan Yin Zi Zai Gong level 1)
Number of subjects: 72
Study: 30658378

Group type: EXPERIMENTAL
Intervention: Coca-Cola
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fanta Orange Soda
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Guaraná Antarctica
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sprite
Number of subjects: 150

Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 150
Study: 26805435

Group type: EXPERIMENTAL
Intervention: Rufinamide
Number of subjects: 37

Group type: COMPARATOR
Intervention: Any other approved AED
Number of subjects: 37
Study: 24004292

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (200,000 IU for 2 months, then 100,000 IU monthly for 18 months)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 22453821

Group type: EXPERIMENTAL
Intervention: Team-based reflection with trained facilitators meeting for up to eleven 1-hour meetings.
Number of subjects: 4
Study: 19089875

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention program delivered by caregivers
Number of subjects: 27

Group type: COMPARATOR
Intervention: Home safety assessment control
Number of subjects: 27